In particular, the percentages of HLA-G-positive monocytes and HLA-G-expressing CD4+, CD8+, and CD4+/CD8+ double positive (DP) cells are significantly higher in SLE patients than in controls. This evidence concerns the gene CD8A and systemic lupus erythematosus.